维普中文期刊产品整合服务
196篇 您的检索式:作者名="LIAW Y F"
    题名 作者 年代 出处 被引量
1Acute exacerbation and hepatits B virus clearance after emergence of YMDD motif mutantion lamivudine therapy显示文摘LIAW Y F CHIEN R N YEH C T 1999Hepatology1999,20,2:2
2Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy 显示文摘Liaw Y F Chien R N Yeh C T 1999Hepatology1999,30,2:1
3Asian-Pacific consensus statement on the management of chronic hepatitis B:a 2008update显示文摘Liaw Y F Leung N Kao J H 2008Hepatol Int2008,2,3:1
4Genoyypie resustance to lamivudine in a prospective, placebo2controlled multicentre study in Asia of larnivudine therapy for chronic hepatitis B infection: incidence, kinetics of emergence, and correlation with disease parameters显示文摘Lai C L Liaw Y F Leung N W 1997Hepatology1997,26,4:1
5Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B:a prospective double-blined placebocontrolled trial显示文摘Liaw Y F Sung J J Y Chow W C 2003Hepatology2003,,:1
6Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease 显示文摘Liaw Y F Sung J J Chow W C 2004N Engl J Med2004,351,15:1
7Impact of YMDD Mutations During Lamivudine Therapy in Patients with Chronic Hepatitis B显示文摘LIAW Y F 2001Antivir Chemother2001,12,1:1
8Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and contin- ued histological improvement in patients with chronic hepatitis B显示文摘Chang T T Liaw Y F Wu S S 2010Hepatology2010,52,3:1
9Lamivudine for patients with chronic hepatitis B and advanced liver disease显示文摘LIAW Y F SUNG J J CHOW W C 2004N Engl J Med2004,351,15:1
10AsianPacific consensus statement on the management of chronic hepatitis B: a 2008 update显示文摘Liaw Y F Leung N Kao J H 2008Hepatol Int2008,2,3:1
11Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study 显示文摘Liaw Y F Raptopoulou-Gigi M Cheinquer H 2011Hepatology2011,54,1:1
12Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B:a prospective double-blined placebo-controlled clinical trial显示文摘Liaw Y F Sung T T Chow W C 2003Hepatology2003,,:1
13Impact of acute hepatitis C virus superinfection !n patients with chronic hepatitis B virus infection 显示文摘Liaw Y F Chen Y C Sheen I S 2004Gastroenterology2004,126,:1
14Hepatitis B virus-related cirrhosis; natural history and treatment 显示文摘CHU C M LIAW Y F 2006Semin Liver Dis2006,26,2:1
15Rescue therapy for lamivudine-resistant chronic hepatitis B:when and how显示文摘LIAW Y F 2007Hepatology2007,45,2:1
16Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompen- sated chronic hepatitis B liver disease显示文摘Liaw Y F Sheen I S Lee C M 2011Hepatology2011,53,1:1
17Genotype C hepatitis B virus infec tion is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B:a longitudinal study of hepatitis B e an tigen-positive patients with normal aminotransferase levels at ba显示文摘Chu C M Liaw Y F 0,,03:1
18Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy显示文摘Liaw Y F 2013J Hepatol2013,59,4:1
19Hepatitis B Virus Infection显示文摘Liaw Y F Chu C M 2009Lancet2009,373,9663:1
20Telbivudine (LdT) vs lamivudine for chronichepatitis B: first-year results from the International Phase Ⅲ GLOBE Trial 显示文摘LAI C L GANE E LIAW y F 2005Hepatology2005,42,11:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费